A drug discovery company co-founded by researchers at the University of Dundee and the University of Arizona has received $4 million in venture funding. Branch Therapeutics, founded in November 2024, is a preclinical stage company seeking to develop drugs that are orally bioavailable, well-tolerated, and can treat multiple cancer types. Its technologies are based on […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!